Vitamins
What Happens to Vitamin D Levels in PCOS?
Women with PCOS are significantly more likely to be vitamin D deficient than those without — and that deficiency isn't just a side effect. Low vitamin D actively worsens insulin resistance, amplifies androgen signaling, and disrupts ovulation. Understanding the connection is a practical first step toward better symptom management.
What Happens to Vitamin D Levels in PCOS?
Vitamin D levels are lower in most women with PCOS than in age-matched controls, and the gap is clinically meaningful — not just a lab curiosity. A 2019 meta-analysis of 31 studies found that women with PCOS had serum 25(OH)D concentrations roughly 5–7 ng/mL below controls, and deficiency (below 20 ng/mL) was present in up to 85% of PCOS cases (Lagowska et al., Nutrients 2018; PMID: 30400307). The main caveat: supplementing vitamin D corrects some downstream problems (insulin resistance, AMH regulation, cycle regularity) but doesn't reverse PCOS itself. The exception is women who are severely deficient — they tend to see the most dramatic symptomatic improvement after repletion.
---
Why Vitamin D Deficiency Is So Common in PCOS
The relationship between PCOS and vitamin D runs in both directions, making deficiency hard to escape once it takes hold.
Adipose tissue sequesters vitamin D. Vitamin D is fat-soluble, meaning excess body fat acts as a reservoir that pulls circulating 25(OH)D out of the bloodstream. Since central adiposity is common in PCOS, this volumetric dilution alone can push levels below the functional threshold.
Insulin resistance impairs vitamin D metabolism. The conversion of vitamin D to its active form (calcitriol) depends on enzymes in the liver and kidney that are sensitive to metabolic health. Insulin resistance — already a hallmark of PCOS — disrupts this conversion pathway, so even women with moderate sun exposure can end up with poor circulating levels (Lerchbaum & Obermayer-Pietsch, European Journal of Endocrinology 2012; PMID: 22275473).
VDR polymorphisms are overrepresented. Studies have found that women with PCOS are more likely to carry variants in the vitamin D receptor (VDR) gene — particularly FokI and BsmI polymorphisms — that reduce receptor sensitivity. This means that even at the same serum concentration, a woman with PCOS may get less physiological signal from the same amount of vitamin D (Mahmoudi 2009; PMID: 19175073).
Chronic low-grade inflammation amplifies the deficit. PCOS is characterized by elevated inflammatory cytokines (IL-6, TNF-α, CRP). Vitamin D is a potent immune modulator; when inflammation is high, its anti-inflammatory functions consume circulating stores faster. The result is a feedback loop: deficiency permits inflammation, and inflammation accelerates deficiency.
If you want to understand how the hormonal picture in PCOS compounds these nutrient deficits, the article on what happens to testosterone in PCOS provides useful context — elevated androgens and vitamin D metabolism are not independent systems.
---
How Low Vitamin D Affects the Core Features of PCOS
Insulin Resistance and Blood Sugar Regulation
Vitamin D upregulates the expression of insulin receptors in peripheral tissues and stimulates insulin secretion from pancreatic beta cells. In deficiency, both mechanisms weaken, deepening insulin resistance. A randomized controlled trial of 60 women with PCOS found that 50,000 IU of vitamin D3 weekly for 8 weeks significantly improved fasting insulin, HOMA-IR, and fasting glucose compared to placebo (Rashidi et al., Gynecological Endocrinology 2009; PMID: 19929051).
Androgen Levels and Symptoms
The link between vitamin D and androgens is less direct but real. Calcitriol modulates the activity of 17α-hydroxylase, the enzyme that drives androgen synthesis in the ovaries and adrenal glands. Studies have shown that vitamin D supplementation reduces total testosterone and free androgen index in women with PCOS, though the effect is modest — roughly a 10–20% reduction in free testosterone in trials lasting 12 weeks or longer (Irani & Merhi, European Journal of Obstetrics & Gynecology and Reproductive Biology 2014; PMID: 24456699).
For a full picture of how DHEA-S levels shift in PCOS, particularly the adrenal androgen piece that vitamin D also touches, that explainer is worth reading alongside this one.
Menstrual Regularity and Ovulation
Vitamin D receptors are expressed in granulosa cells, the cells that surround and nourish developing follicles. Adequate vitamin D appears necessary for normal follicular development and for the LH surge that triggers ovulation. Observational data consistently show that PCOS women with sufficient vitamin D (above 30 ng/mL) have more regular cycles and better ovulatory frequency than those who are deficient — though randomized trial evidence for cycle regularization specifically is still emerging.
AMH and Ovarian Reserve Signaling
Anti-Müllerian hormone (AMH) is chronically elevated in PCOS and is one reason follicles stall rather than completing maturation. Vitamin D has been shown to suppress AMH gene expression in granulosa cells in vitro and to modestly reduce serum AMH in supplementation trials. This may be one mechanism through which vitamin D repletion improves follicular dynamics in PCOS (Irani & Merhi, 2014; PMID: 24456699).
Mood, Stress, and Inflammatory Flares
Many women with PCOS notice that emotional stress makes symptoms worse — cycle disruption, acne, and hair shedding can all worsen in high-stress periods. This isn't imaginary. Stress elevates cortisol, which suppresses vitamin D conversion and independently drives inflammation. Vitamin D itself modulates the HPA axis and supports serotonin synthesis, so chronic deficiency removes a buffer against the inflammatory and mood consequences of stress. Maintaining adequate vitamin D status is one of the more evidence-based strategies for dampening these stress-driven flare cycles.
The interplay between stress and PCOS symptom variability is explored in depth in the article on why PCOS symptoms change week to week — highly relevant if your flares feel unpredictable.
---
What the Research Says About Supplementation
| Parameter | Effect of Vitamin D Supplementation | Quality of Evidence |
|---|---|---|
| Fasting insulin / HOMA-IR | Significant reduction in deficient women | RCTs, meta-analyses |
| Total testosterone | Modest reduction (~10–20%) | RCTs |
| Free androgen index | Reduction in longer trials (≥12 wk) | RCTs |
| Serum AMH | Reduction in granulosa cell expression | RCTs + in vitro |
| Cycle regularity | Trend toward improvement; data maturing | Observational + small RCTs |
| CRP / inflammatory markers | Reduction in high-dose protocols | RCTs |
| Mood / depressive symptoms | Modest improvement in deficient subjects | Meta-analyses |
Dose matters. Most trials showing metabolic benefits used doses between 2,000 IU and 4,000 IU daily (or equivalent weekly doses), targeting serum 25(OH)D above 30 ng/mL. Trials using 800–1,000 IU — the typical RDA-adjacent range — show weaker effects, likely because they are insufficient to fully correct deficiency in this population.
---
Vitamin D and B12: A Common Dual Deficiency in PCOS
It's worth flagging that vitamin D rarely operates in isolation. Women with PCOS — particularly those on metformin — are also at high risk for B12 depletion. Metformin impairs B12 absorption through the ileum, and this often goes undetected because standard PCOS bloodwork doesn't include B12. If you're managing PCOS with metformin or suspect nutrient gaps beyond vitamin D, the article on what happens to B12 in PCOS is directly relevant.
Other B-vitamin gaps — including vitamin B6 deficiency, which affects dopamine and progesterone metabolism — also compound the PCOS hormonal picture. Addressing vitamin D without auditing the broader micronutrient landscape means leaving other levers unpulled.
---
Vitamin D3 + K2: Why the Pairing Matters
Vitamin D3 supplementation raises serum calcium and promotes calcium absorption — a good thing for bone density, but potentially problematic if calcium is deposited in soft tissues (arteries, kidneys) rather than bone. Vitamin K2 in its MK-7 form activates matrix Gla-protein (MGP) and osteocalcin, proteins that direct calcium into bone and keep it out of vascular tissue.
For women with PCOS, who already carry elevated cardiovascular risk due to insulin resistance and dyslipidemia, combining D3 with K2 is not just a theoretical precaution — it's clinically sound practice. A 3-year randomized trial found that MK-7 supplementation (180 mcg/day) significantly improved vascular stiffness markers in healthy postmenopausal women, suggesting active cardioprotective benefit from K2 at doses used in practice (Knapen et al., Thrombosis and Haemostasis 2015; PMID: 25694037).
Note: the article on vitamin K deficiency symptoms and lab markers covers the full spectrum of K2's role and how to identify gaps through standard bloodwork.
---
How Ones Addresses This
Ones uses an AI health practitioner model that analyzes blood work (including 25(OH)D, fasting insulin, and relevant hormones), wearable data, and health history to build a custom capsule formula. For women with PCOS and confirmed vitamin D deficiency, the formula typically includes:
- Vitamin D3 + K2 (MK-7): Ones pairs D3 with vitamin K2 in the MK-7 form at clinically relevant doses — matching the protocol used in vascular and bone health trials. The pairing isn't incidental; it's built into the formulation to address the calcium-routing concern that matters in a population with elevated cardiovascular risk.
- Magnesium Glycinate: Magnesium is a cofactor for the enzymatic conversion of vitamin D to its active form. Deficiency in magnesium — common in PCOS — can blunt the response to vitamin D supplementation regardless of dose. Ones includes magnesium glycinate for its high bioavailability and its direct role in making supplemented D3 actually work.
- Zinc: Zinc supports VDR (vitamin D receptor) activity and is independently depleted in PCOS, particularly in women with elevated insulin. Including zinc alongside D3 improves receptor sensitivity and closes a gap that vitamin D alone cannot address.
Formulas are built as 6 or 9-capsule daily plans, calibrated by the AI based on your individual findings — not chosen off a menu. The goal is precision: the right nutrients at clinical doses, without guesswork.
---
Key Takeaways
- Vitamin D deficiency is nearly universal in PCOS — present in up to 85% of cases — and is caused by a combination of adipose sequestration, insulin resistance impairing conversion, VDR polymorphisms, and chronic inflammation.
- Low vitamin D worsens the core features of PCOS: it deepens insulin resistance, amplifies androgen signaling, stalls follicular development, and removes a buffer against inflammatory stress flares.
- Supplementation at adequate doses (2,000–4,000 IU/day) improves insulin sensitivity, modestly reduces androgen levels, and may improve cycle regularity — especially in women who were significantly deficient at baseline.
- Pairing D3 with K2 (MK-7) is clinically warranted in PCOS due to elevated cardiovascular risk; K2 ensures calcium deposited through D3 supplementation is directed to bone rather than arterial walls.
- Magnesium and zinc are essential cofactors — without them, vitamin D supplementation may underperform regardless of dose.
- Vitamin D doesn't work in isolation. Addressing the full micronutrient picture — including B12, B6, and K2 — is necessary for meaningful improvement in PCOS symptoms.
---
This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting or adjusting any supplement protocol.